A detailed history of Clarius Group, LLC transactions in Accolade, Inc. stock. As of the latest transaction made, Clarius Group, LLC holds 10,585 shares of ACCD stock, worth $38,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,585
Previous 10,585 -0.0%
Holding current value
$38,529
Previous $37,000 8.11%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$9.22 - $15.02 $110,640 - $180,240
-12,000 Reduced 53.13%
10,585 $110,000
Q4 2022

Jan 25, 2023

BUY
$7.19 - $13.16 $86,280 - $157,920
12,000 Added 113.37%
22,585 $176,000
Q4 2021

Feb 02, 2022

BUY
$21.96 - $42.69 $232,446 - $451,873
10,585 New
10,585 $279,000

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $262M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.